On July 11, the Chinese Pharmacopoeia (ChP) Commission announced that it would conduct systemic research on the standards of colourants as pharmaceuti…
On July 8, China National Medical Products Administration (NMPA) released the Administrative Rules on Vaccine Manufacture and Distribution (hereafter …
On July 13, the Chinese Pharmacopoeia (ChP) Commission released the drafts of 3 general chapters and 8 determination methods of rubber closures as pha…
On July 13, the National Joint Drug Procurement Office announced the preliminary result for the bid of the 7th round of volume-based procurement (VBP)…
In the first half of 2022, China National Medical Products Administration (NMPA) approved 210 domestically-manufactured generic drugs for marketing au…
Editor\’s Notes: New drugs in this article refer to Innovative/improved new chemical drugs / biological products that have never been granted ma…
This is a collection of China\’s recent pharmaceutical laws, regulations, policies, and standards, mainly issued by the following authorities: N…
On June 1, China Center for Drug Evaluation (CDE) released the 2021 China Drug Evaluation Report. ChemLinked BaiPharm Team selected excerpts from the …
On June 29, 2022, China National Healthcare Security Administration (NHSA) issued the Work Plan for Adjusting the 2022 National Reimbursement Drug Lis…
